Long non‑coding RNAs as potential therapeutic targets in non‑small cell lung cancer (Review)

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar

Xie S, Wu Z, Qi Y, Wu B and Zhu X: The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges. Biomed Pharmacother. 138:1114502021. View Article : Google Scholar

Campbell JD, Alexandrov A, Kim J, Wala J, Berger AH, Pedamallu CS, Shukla SA, Guo G, Brooks AN, Murray BA, et al: Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 48:607–616. 2016. View Article : Google Scholar : PubMed/NCBI

Chaft JE, Rimner A, Weder W, Azzoli CG, Kris MG and Cascone T: Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer. Nat Rev Clin Oncol. 18:547–557. 2021. View Article : Google Scholar : PubMed/NCBI

Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, Mariotto AB, Lowy DR and Feuer EJ: The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 383:640–649. 2020. View Article : Google Scholar

Siegel RL, Miller KD, Fuchs HE and Jemal A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021. View Article : Google Scholar : PubMed/NCBI

Sheng GT, Duan HJ, Sun ZG and Chu HQ: Advances in therapeutic nanodrug delivery systems for infectious lung diseases: A review. Acta Materia Medica. 1:343–364. 2022. View Article : Google Scholar

Ginn L, Shi L, Montagna M and Garofalo M: LncRNAs in non-small-cell lung cancer. Noncoding RNA. 6:252020.PubMed/NCBI

Li Z, Meng X, Wu P, Zha C, Han B, Li L, Sun N, Qi T, Qin J, Zhang Y, et al: Glioblastoma Cell-Derived lncRNA-containing exosomes induce microglia to produce complement C5, promoting chemotherapy resistance. Cancer Immunol Res. 9:1383–1399. 2021. View Article : Google Scholar

Rinn JL and Chang HY: Genome regulation by long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar

Bánfai B, Jia H, Khatun J, Wood E, Risk B, Gundling WE Jr, Kundaje A, Gunawardena HP, Yu Y, Xie L, et al: Long noncoding RNAs are rarely translated in two human cell lines. Genome Res. 22:1646–1657. 2012. View Article : Google Scholar :

Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al: Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar :

Wang S, Zeng F, Liang S, Wang Q, Wen Y, Wang Q, Zhang J, Li M, Fang S, Wei T, et al: lncRNA Linc00173 modulates glucose metabolism and multidrug chemoresistance in SCLC: Potential molecular panel for targeted therapy. Mol Ther. 30:17872022. View Article : Google Scholar :

Qiao Y, Jin T, Guan S, Cheng S, Wen S, Zeng H, Zhao M, Yang L, Wan X, Qiu Y, et al: Long non-coding RNA Lnc-408 promotes invasion and metastasis of breast cancer cell by regulating LIMK1. Oncogene. 40:4198–4213. 2021. View Article : Google Scholar : PubMed/NCBI

Du M, Zheng R, Ma G, Chu H, Lu J, Li S, Xin J, Tong N, Zhang G, Wang W, et al: Remote modulation of lncRNA GCLET by risk variant at 16p13 underlying genetic susceptibility to gastric cancer. Sci Adv. 6:eaay55252020. View Article : Google Scholar : PubMed/NCBI

Zhao W and Xie Q: Exosomal lncRNA-Mediated intercellular communication promotes glioblastoma chemoresistance. Cancer Immunol Res. 9:13722021. View Article : Google Scholar : PubMed/NCBI

Zhang B, Zhang M, Yang Y, Li Q, Yu J, Zhu S, Niu Y and Shang Z: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC. Oncogene. 41:387–399. 2022. View Article : Google Scholar :

Meessen J, Bär C, di Dona FM, Staszewsky LI, Di Giulio P, Di Tano G, Costa A, Leonardy J, Novelli D, Nicolis EB, et al: LIPCAR Is increased in chronic symptomatic HF patients. A Sub-Study of the GISSI-HF trial. Clin Chem. 67:1721–1731. 2021. View Article : Google Scholar : PubMed/NCBI

Zheng X, Zhang J, Fang T, Wang X, Wang S, Ma Z, Xu Y, Han C, Sun M, Xu L, et al: The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway. Oncogenesis. 9:342020. View Article : Google Scholar : PubMed/NCBI

Eidem TM, Kugel JF and Goodrich JA: Noncoding RNAs: Regulators of the mammalian transcription machinery. J Mol Biol. 428:2652–2659. 2016. View Article : Google Scholar : PubMed/NCBI

Tao H, Zhang Y, Li J, Liu J, Yuan T, Wang W, Liang H, Zhang E and Huang Z: Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma. Mol Ther Oncolytics. 28:88–103. 2023. View Article : Google Scholar :

Liu B, Qu X, Wang J, Xu L, Zhang L, Xu B, Su J and Bian X: LINC00365 functions as a tumor suppressor by inhibiting HIF-1α-mediated glucose metabolism reprogramming in breast cancer. Exp Cell Res. 425:1135142023. View Article : Google Scholar

Kopp F and Mendell JT: Functional classification and experimental dissection of long noncoding RNAs. Cell. 172:393–407. 2018. View Article : Google Scholar :

Brownmiller T, Juric JA, Ivey AD, Harvey BM, Westemeier ES, Winters MT, Stevens AM, Stanley AN, Hayes KE, Sprowls SA, et al: Y Chromosome LncRNA are involved in radiation response of male non-small cell lung cancer cells. Cancer Res. 80:4046–4057. 2020. View Article : Google Scholar : PubMed/NCBI

Sun Q, Hao Q and Prasanth KV: Nuclear long noncoding RNAs: Key regulators of gene expression. Trends Genet. 34:142–157. 2018. View Article : Google Scholar :

Noh JH, Kim KM, McClusky WG, Abdelmohsen K and Gorospe M: Cytoplasmic functions of long noncoding RNAs. Wiley Interdiscip Rev RNA. 9:e14712018. View Article : Google Scholar : PubMed/NCBI

Jing X, Yang F, Shao C, Wei K, Xie M, Shen H and Shu Y: Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 18:1572019. View Article : Google Scholar : PubMed/NCBI

Kashihara M, Azuma K, Kawahara A, Basaki Y, Hattori S, Yanagawa T, Terazaki Y, Takamori S, Shirouzu K, Aizawa H, et al: Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer. J Thorac Oncol. 4:1066–1074. 2009. View Article : Google Scholar : PubMed/NCBI

Cui Y, Li F, Xie Q, Zhao S, Guo T, Guo P, Hu S, Hao J, Tian C, Yu W, et al: YBX1 mediates autophagy by targeting p110β and decreasing the sensitivity to cisplatin in NSCLC. Cell Death Dis. 11:4762020. View Article : Google Scholar

Zhao Y, Zhou L, Li H, Sun T, Wen X, Li X, Meng Y, Li Y, Liu M, Liu S, et al: Nuclear-Encoded lncRNA MALAT1 epigenetically controls metabolic reprogramming in HCC cells through the mitophagy pathway. Mol Ther Nucleic Acids. 23:264–276. 2021. View Article : Google Scholar

Cao DW, Liu MM, Duan R, Tao YF, Zhou JS, Fang WR, Zhu JR, Niu L and Sun JG: The lncRNA Malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation. Acta Pharmacol Sin. 41:22–33. 2020. View Article : Google Scholar

Barik GK, Sahay O, Behera A, Naik D and Kalita B: Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application. Biochim Biophys Acta Rev Cancer. 1876:1886122021. View Article : Google Scholar : PubMed/NCBI

Knutsen E, Harris AL and Perander M: Expression and functions of long non-coding RNA NEAT1 and isoforms in breast cancer. Br J Cancer. 126:551–561. 2022. View Article : Google Scholar

Wang D, Zhang S, Zhao M and Chen F: LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis. Cancer Med. 9:9138–9149. 2020. View Article : Google Scholar : PubMed/NCBI

Li M, Shi M, Hu C, Chen B and Li S: MALAT1 modulated FOXP3 ubiquitination then affected GINS1 transcription and drived NSCLC proliferation. Oncogene. 40:3870–3884. 2021. View Article : Google Scholar : PubMed/NCBI

Yang L, Chen Y, Cui T, Knösel T, Zhang Q, Albring KF, Huber O and Petersen I: Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer. Carcinogenesis. 33:1863–1870. 2012. View Article : Google Scholar : PubMed/NCBI

Wang R, Liu J, Li K, Yang G, Chen S, Wu J, Xie X, Ren H and Pang Y: An SETD1A/Wnt/β-catenin feedback loop promotes NSCLC development. J Exp Clin Cancer Res. 40:3182021. View Article : Google Scholar

Liao Y, Feng J, Sun W, Wu C, Li J, Jing T, Liang Y, Qian Y, Liu W, Wang H, et al: CIRP promotes the progression of non-small cell lung cancer through activation of Wnt/β-catenin signaling via CTNNB1. J Exp Clin Cancer Res. 40:2752021. View Article : Google Scholar

Shapiro M, Akiri G, Chin C, Wisnivesky JP, Beasley MB, Weiser TS, Swanson SJ and Aaronson SA: Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancer. Ann Surg. 257:548–554. 2013. View Article : Google Scholar

Pang B, Wang Y and Chang X: A Novel Tumor suppressor gene, ZNF24, inhibits the development of NSCLC by inhibiting the WNT signaling pathway to induce cell senescence. Front Oncol. 11:6643692021. View Article : Google Scholar : PubMed/NCBI

Zhang K, Wang J, Yang L, Yuan YC, Tong TR, Wu J, Yun X, Bonner M, Pangeni R, Liu Z, et al: Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer. Mol Cancer. 17:1532018. View Article : Google Scholar

Han X, Jiang H, Qi J, Li J, Yang J, Tian Y, Li W, Jing Q and Wang C: Novel lncRNA UPLA1 mediates tumorigenesis and prognosis in lung adenocarcinoma. Cell Death Dis. 11:9992020. View Article : Google Scholar : PubMed/NCBI

Wang J, Cai H, Dai Z and Wang G: Down-regulation of lncRNA XIST inhibits cell proliferation via regulating miR-744/RING1 axis in non-small cell lung cancer. Clin Sci (Lond). 133:1567–1579. 2019. View Article : Google Scholar : PubMed/NCBI

Kun E, Tsang YTM, Ng CW, Gershenson DM and Wong KK: MEK inhibitor resistance mechanisms and recent developments in combination trials. Cancer Treat Rev. 92:1021372021. View Article : Google Scholar

Weissman R, Diamond EL, Haroche J, Durham BH, Cohen F, Buthorn J, Amoura Z, Emile JF, Mazor RD, Shomron N, et al: MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis. Leukemia. 36:1139–1149. 2022. View Article : Google Scholar :

Han J, Liu Y, Yang S, Wu X, Li H and Wang Q: MEK inhibitors for the treatment of non-small cell lung cancer. J Hematol Oncol. 14:12021. View Article : Google Scholar : PubMed/NCBI

Liu HY, Lu SR, Guo ZH, Zhang ZS, Ye X, Du Q, Li H, Wu Q, Yu B, Zhai Q, et al: lncRNA SLC16A1-AS1 as a novel prognostic biomarker in non-small cell lung cancer. J Investig Med. 68:52–59. 2020. View Article : Google Scholar :

Logotheti S, Marquardt S, Gupta SK, Richter C, Edelhäuser BAH, Engelmann D, Brenmoehl J, Söhnchen C, Murr N, Alpers M, et al: LncRNA-SLC16A1-AS1 induces metabolic reprogramming during bladder cancer progression as target and co-activator of E2F1. Theranostics. 10:9620–9643. 2020. View Article : Google Scholar : PubMed/NCBI

Zang X, Gu J, Zhang J, Shi H, Hou S, Xu X, Chen Y, Zhang Y, Mao F, Qian H, et al: Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression. Cell Death Dis. 11:2152020. View Article : Google Scholar : PubMed/NCBI

Yang Z, Lin X, Zhang P, Liu Y, Liu Z, Qian B, Liu X and Shao G: Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis. Biomed Pharmacother. 124:1098582020. View Article : Google Scholar : PubMed/NCBI

Fang P, Chen H, Ma Z, Han C, Yin W, Wang S, Zhu H, Xia W, Wang J, Xu L, et al: LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex-mediated changes in chromatin structure in lung adenocarcinoma. Cancer Commun (Lond). 41:596–614. 2021. View Article : Google Scholar : PubMed/NCBI

Yang M, He X, Huang X, Wang J, He Y and Wei L: LncRNA MIR4435-2HG-mediated upregulation of TGF-β1 promotes migration and proliferation of nonsmall cell lung cancer cells. Environ Toxicol. 35:582–590. 2020. View Article : Google Scholar

Xu F, Hua Q, Zhang A, Di Z, Wang Y, Zhao L, Yang H, Liu J and Huang G: LncRNA AC020978 facilitates non-small cell lung cancer progression by interacting with malate dehydrogenase 2 and activating the AKT pathway. Cancer Sci. 112:4501–4514. 2021. View Article : Google Scholar : PubMed/NCBI

Cai Y, Wu Q, Liu Y and Wang J: AZIN1-AS1, A novel oncogenic LncRNA, promotes the progression of non-small cell lung cancer by regulating MiR-513b-5p and DUSP11. Onco Targets Ther. 13:9667–9678. 2020. View Article : Google Scholar : PubMed/NCBI

Wu S, Liu B, Zhang Y, Hong R, Liu S, Xiang T, Tao T, Cai J, Wu J, Li M and Guan H: Long non-coding RNA LEISA promotes progression of lung adenocarcinoma via enhancing interaction between STAT3 and IL-6 promoter. Oncogene. 40:3449–3459. 2021. View Article : Google Scholar : PubMed/NCBI

Wang RQ, Long XR, Zhou NN, Chen DN, Zhang MY, Wen ZS, Zhang LJ, He FZ, Zhou ZL, Mai SJ and Wang HY: Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer. J Exp Clin Cancer Res. 40:92021. View Article : Google Scholar : PubMed/NCBI

Li C, Zhao W, Pan X, Li X, Yan F, Liu S, Feng J and Lu J: LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1. Oncogene. 39:6157–6171. 2020. View Article : Google Scholar : PubMed/NCBI

Liu C, Li X, Hao Y, Wang F, Cheng Z, Geng H and Geng D: STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis. Aging (Albany NY). 12:8680–8701. 2020. View Article : Google Scholar : PubMed/NCBI

Zhu Y, Li J, Bo H, He D, Xiao M, Xiang L, Gong L, Hu Y, Zhang Y, Cheng Y, et al: LINC00467 is up-regulated by TDG-mediated acetylation in non-small cell lung cancer and promotes tumor progression. Oncogene. 39:6071–6084. 2020. View Article : Google Scholar : PubMed/NCBI

Yang J, Liu Y, Mai X, Lu S, Jin L and Tai X: STAT1-induced upregulation of LINC00467 promotes the proliferation migration of lung adenocarcinoma cells by epigenetically silencing DKK1 to activate Wnt/β-catenin signaling pathway. Biochem Biophys Res Commun. 514:118–126. 2019. View Article : Google Scholar : PubMed/NCBI

Chang Y and Yang L: LINC00467 promotes cell proliferation and stemness in lung adenocarcinoma by sponging miR-4779 and miR-7978. J Cell Biochem. 121:3691–3699. 2019. View Article : Google Scholar : PubMed/NCBI

Xue F, Yang C, Yun K, Jiang C, Cai R, Liang M, Wang Q, Bian W, Zhou H, Liu Z and Zhu L: RETRACTED ARTICLE: Reduced LINC00467 elevates microRNA-125a-3p to suppress cisplatin resistance in non-small cell lung cancer through inhibiting sirtuin 6 and inactivating the ERK1/2 signaling pathway. Cell Biol Toxicol. 39:3652023. View Article : Google Scholar

Yin H, Chen L, Piao S, Wang Y, Li Z, Lin Y, Tang X, Zhang H, Zhang H and Wang X: M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway. Cell Death Differ. 30:605–617. 2023. View Article : Google Scholar

Sun CC, Zhu W, Li SJ, Hu W, Zhang J, Zhuo Y, Zhang H, Wang J, Zhang Y, Huang SX, et al: Correction to: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway. Genome Med. 13:252021. View Article : Google Scholar

Shi L, Magee P, Fassan M, Sahoo S, Leong HS, Lee D, Sellers R, Brullé-Soumaré L, Cairo S, Monteverde T, et al: A KRAS-responsive long non-coding RNA controls microRNA processing. Nat Commun. 12:20382021. View Article : Google Scholar : PubMed/NCBI

La Montagna M, Shi L, Magee P, Sahoo S, Fassan M and Garofalo M: AMPKα loss promotes KRAS-mediated lung tumorigenesis. Cell Death Differ. 28:2673–2689. 2021. View Article : Google Scholar : PubMed/NCBI

Shi J, Yang C, An J, Hao D, Liu C, Liu J, Sun J and Jiang J: KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway. J Exp Clin Cancer Res. 40:1482021. View Article : Google Scholar : PubMed/NCBI

Ni J, Zhang X, Li J, Zheng Z, Zhang J, Zhao W and Liu L: Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts. Cell Death Dis. 12:6622021. View Article : Google Scholar : PubMed/NCBI

Lv X, Lian Y, Liu Z, Xiao J, Zhang D and Yin X: Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d/E2F1 axis. Aging (Albany NY). 13:6010–6024. 2021. View Article : Google Scholar : PubMed/NCBI

Liu S, Zhan N, Gao C, Xu P, Wang H, Wang S, Piao S and Jing S: Long noncoding RNA CBR3-AS1 mediates tumorigenesis and radiosensitivity of non-small cell lung cancer through redox and DNA repair by CBR3-AS1/miR-409-3p/SOD1 axis. Cancer Lett. 526:1–11. 2022. View Article : Google Scholar

Wang C, Meng X, Zhou Y, Yu J, Li Q, Liao Z, Gu Y, Han J, Linghu S, Jiao Z, et al: Long Noncoding RNA CTD-2245E15.3 Promotes Anabolic Enzymes ACC1 and PC to support non-small cell lung cancer growth. Cancer Res. 81:3509–3524. 2021. View Article : Google Scholar : PubMed/NCBI

Wang S, Wang T, Liu D and Kong H: LncRNA MALAT1 aggravates the progression of non-small cell lung cancer by stimulating the expression of COMMD8 via targeting miR-613. Cancer Manag Res. 12:10735–10747. 2020. View Article : Google Scholar : PubMed/NCBI

Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, Di W, Hu B, An J, Kong L, et al: m⁶A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis. J Hematol Oncol. 12:1352019. View Article : Google Scholar

Jin S, He J, Zhou Y, Wu D, Li J and Gao W: LncRNA FTX activates FOXA2 expression to inhibit non-small-cell lung cancer proliferation and metastasis. J Cell Mol Med. 24:4839–4849. 2020. View Article : Google Scholar : PubMed/NCBI

Sun J, Xiong Y, Jiang K, Xin B, Jiang T, Wei R, Zou Y, Tan H, Jiang T, Yang A, et al: Hypoxia-sensitive long noncoding RNA CASC15 promotes lung tumorigenesis by regulating the SOX4/β-catenin axis. J Exp Clin Cancer Res. 40:122021. View Article : Google Scholar

Fan H, Yuan J, Li Y, Jia Y, Li J, Wang X and Li X: MKL1-induced lncRNA SNHG18 drives the growth and metastasis of non-small cell lung cancer via the miR-211-5p/BRD4 axis. Cell Death Dis. 12:1282021. View Article : Google Scholar : PubMed/NCBI

Chen J, Liu A, Wang Z, Wang B, Chai X, Lu W, Cao T, Li R, Wu M, Lu Z, et al: LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression. Mol Cancer. 19:982020. View Article : Google Scholar : PubMed/NCBI

Xiao L, Li Y, Zeng X, Zhou Z, Hu S, Zhang S, Zhou Y, Zhang Z, Zhao H, Zhao H, et al: Silencing of LOC389641 impairs cell proliferation and induces autophagy via EGFR/MET signaling in lung adenocarcinoma. Aging (Albany NY). 13:2539–2552. 2020. View Article : Google Scholar : PubMed/NCBI

Cao G, Tan B, Wei S, Shen W, Wang X, Chu Y, Rong T and Gao C: Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p. Biomed Pharmacother. 125:1098562020. View Article : Google Scholar : PubMed/NCBI

Hua Q, Mi B, Xu F, Wen J, Zhao L, Liu J and Huang G: Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis. Theranostics. 10:4762–4778. 2020. View Article : Google Scholar :

Chen Q, Guo SM, Huang HQ, Huang GP, Li Y, Li ZH, Huang R, Xiao L, Fan CR, Yuan Q and Zheng SL: Long noncoding RNA SBF2-AS1 contributes to the growth and metastatic phenotypes of NSCLC via regulating miR-338-3p/ADAM17 axis. Aging (Albany NY). 12:17902–17920. 2020. View Article : Google Scholar : PubMed/NCBI

Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6. 1990. View Article : Google Scholar : PubMed/NCBI

Quinodoz SA, Jachowicz JW, Bhat P, Ollikainen N, Banerjee AK, Goronzy IN, Blanco MR, Chovanec P, Chow A, Markaki Y, et al: RNA promotes the formation of spatial compartments in the nucleus. Cell. 184:5775–5790.e5730. 2021. View Article : Google Scholar : PubMed/NCBI

Markaki Y, Gan Chong J, Wang Y, Jacobson EC, Luong C, Tan SYX, Jachowicz JW, Strehle M, Maestrini D, Banerjee AK, et al: Xist nucleates local protein gradients to propagate silencing across the X chromosome. Cell. 184:6174–6192.e6132. 2021. View Article : Google Scholar : PubMed/NCBI

Guo Z, Dai Y, Hu W, Zhang Y, Cao Z, Pei W, Liu N, Nie J, Wu A, Mao W, et al: The long noncoding RNA CRYBG3 induces aneuploidy by interfering with spindle assembly checkpoint via direct binding with Bub3. Oncogene. 40:1821–1835. 2021. View Article : Google Scholar : PubMed/NCBI

Tian B, Han X, Li G, Jiang H, Qi J, Li J, Tian Y and Wang C: A Long intergenic non-coding RNA, LINC01426, promotes cancer progression via AZGP1 and predicts poor prognosis in patients with LUAD. Mol Ther Methods Clin Dev. 18:765–780. 2020. View Article : Google Scholar : PubMed/NCBI

Liu X, Yin Z, Xu L, Liu H, Jiang L, Liu S and Sun X: Upregulation of LINC01426 promotes the progression and stemness in lung adenocarcinoma by enhancing the level of SHH protein to activate the hedgehog pathway. Cell Death Dis. 12:1732021. View Article : Google Scholar : PubMed/NCBI

Jia D, Xing Y, Zhan Y, Cao M, Tian F, Fan W, Huang J, Cui Y, Gu R, Cui Y, et al: LINC02678 as a novel prognostic marker promotes aggressive non-small-cell lung cancer. Front Cell Dev Biol. 9:6869752021. View Article : Google Scholar : PubMed/NCBI

Chen Z, Chen X, Lei T, Gu Y, Gu J, Huang J, Lu B, Yuan L, Sun M and Wang Z: Integrative analysis of NSCLC identifies LINC01234 as an oncogenic lncRNA that interacts with HNRNPA2B1 and regulates miR-106b biogenesis. Mol Ther. 28:1479–1493. 2020. View Article : Google Scholar : PubMed/NCBI

Chen Z, Chen X, Lu B, Gu Y, Chen Q, Lei T, Nie F, Gu J, Huang J, Wei C, et al: Up-regulated LINC01234 promotes non-small-cell lung cancer cell metastasis by activating VAV3 and repressing BTG2 expression. J Hematol Oncol. 13:72020. View Article : Google Scholar : PubMed/NCBI

Zheng F, Li J, Ma C, Tang X, Tang Q, Wu J, Chai X, Xie J, Yang XB and Hann SS: Novel regulation of miR-34a-5p and HOTAIR by the combination of berberine and gefitinib leading to inhibition of EMT in human lung cancer. J Cell Mol Med. 24:5578–5592. 2020. View Article : Google Scholar : PubMed/NCBI

Hua Q, Jin M, Mi B, Xu F, Li T, Zhao L, Liu J and Huang G: LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol. 12:912019. View Article : Google Scholar : PubMed/NCBI

Zhang M, Han Y, Zheng Y, Zhang Y, Zhao X, Gao Z and Liu X: ZEB1-activated LINC01123 accelerates the malignancy in lung adenocarcinoma through NOTCH signaling pathway. Cell Death Dis. 11:9812020. View Article : Google Scholar : PubMed/NCBI

Chen H, Liu H and Qing G: Targeting oncogenic Myc as a strategy for cancer treatment. Signal Transduct Target Ther. 3:52018. View Article : Google Scholar : PubMed/NCBI

Gabay M, Li Y and Felsher DW: MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb Perspect Med. 4:a0142412014. View Article : Google Scholar : PubMed/NCBI

Scafuro M, Capasso L, Carafa V, Altucci L and Nebbioso A: Gene Transactivation and Transrepression in MYC-Driven Cancers. Int J Mol Sci. 22:34582021. View Article : Google Scholar : PubMed/NCBI

Vervoort SJ, van Boxtel R and Coffer PJ: The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe? Oncogene. 32:3397–3409. 2013. View Article : Google Scholar

Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao X, Feng J, Zhang Y, Gao H, Liu DX, et al: SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res. 72:4597–4608. 2012. View Article : Google Scholar : PubMed/NCBI

Sun CC, Zhu W, Li SJ, Hu W, Zhang J, Zhuo Y, Zhang H, Wang J, Zhang Y, Huang SX, et al: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway. Genome Med. 12:772020. View Article : Google Scholar

Lu Z, Fang Z, Guo Y, Liu X and Chen S: Cisplatin resistance of NSCLC cells involves upregulation of visfatin through activation of its transcription and stabilization of mRNA. Chem Biol Interact. 351:1097052022. View Article : Google Scholar

Błach J, Wojas-Krawczyk K, Nicoś M and Krawczyk P: Failure of immunotherapy-the molecular and immunological origin of immunotherapy resistance in lung cancer. Int J Mol Sci. 22:90302021. View Article : Google Scholar

Wang CJ, Zhu CC, Xu J, Wang M, Zhao WY, Liu Q, Zhao G and Zhang ZZ: The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer. 18:1152019. View Article : Google Scholar : PubMed/NCBI

Wei MM and Zhou GB: Long Non-coding RNAs and their roles in non-small-cell lung cancer. Genomics Proteomics Bioinformatics. 14:280–288. 2016. View Article : Google Scholar : PubMed/NCBI

Huang J, Pan B, Xia G, Zhu J, Li C and Feng J: LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1. Cell Death Dis. 11:5252020. View Article : Google Scholar : PubMed/NCBI

Chen Z, Chen Q, Cheng Z, Gu J, Feng W, Lei T, Huang J, Pu J, Chen X and Wang Z: Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1. Cell Death Dis. 11:8582020. View Article : Google Scholar : PubMed/NCBI

Bing Z, Han J, Zheng Z and Liang N: FOXO3-induced oncogenic lncRNA CASC9 enhances gefitinib resistance of non-small-cell lung cancer through feedback loop. Life Sci. 287:1200122021. View Article : Google Scholar : PubMed/NCBI

Li Z, Niu H, Qin Q, Yang S, Wang Q, Yu C, Wei Z, Jin Z, Wang X, Yang A and Chen X: lncRNA UCA1 mediates resistance to cisplatin by regulating the miR-143/FOSL2-Signaling pathway in ovarian cancer. Mol Ther Nucleic Acids. 17:92–101. 2019. View Article : Google Scholar : PubMed/NCBI

Li C, Fan K, Qu Y, Zhai W, Huang A, Sun X and Xing S: Deregulation of UCA1 expression may be involved in the development of chemoresistance to cisplatin in the treatment of non-small-cell lung cancer via regulating the signaling pathway of microRNA-495/NRF2. J Cell Physiol. 235:3721–3730. 2020. View Article : Google Scholar

Xu T, Yan S, Wang M, Jiang L, Ma P, Lu B, Chen Q, Wei C and Wang Z: LncRNA UCA1 induces acquired resistance to gefitinib by epigenetically silencing cdkn1a expression in non-small-cell lung cancer. Front Oncol. 10:6562020. View Article : Google Scholar : PubMed/NCBI

Wang H, Lu B, Ren S, Wu F, Wang X, Yan C and Wang Z: Long Noncoding RNA LINC01116 contributes to gefitinib resistance in non-small cell lung cancer through regulating IFI44. Mol Ther Nucleic Acids. 19:218–227. 2020. View Article : Google Scholar

Fu J, Cai H, Wu Y, Fang S and Wang D: Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis. Gene. 755:1448862020. View Article : Google Scholar : PubMed/NCBI

He H, Song X, Yang Z, Mao Y, Zhang K, Wang Y, Su B, Li Q, Chen H and Li Y: Upregulation of KCNQ1OT1 promotes resistance to stereotactic body radiotherapy in lung adenocarcinoma by inducing ATG5/ATG12-mediated autophagy via miR-372-3p. Cell Death Dis. 11:8832020. View Article : Google Scholar : PubMed/NCBI

Dong Z, Yang P, Qiu X, Liang S, Guan B, Yang H, Li F, Sun L, Liu H, Zou G and Zhao K: KCNQ1OT1 facilitates progression of non-small-cell lung carcinoma via modulating miRNA-27b-3p/HSP90AA1 axis. J Cell Physiol. 234:11304–11314. 2019. View Article : Google Scholar

Shu D, Xu Y and Chen W: Knockdown of lncRNA BLACAT1 reverses the resistance of afatinib to non-small cell lung cancer via modulating STAT3 signalling. J Drug Target. 28:300–306. 2020. View Article : Google Scholar

Ju ZS, Sun B, Bao D and Zhang XF: Effect of lncRNA-BLACAT1 on drug resistance of non-small cell lung cancer cells in DDP chemotherapy by regulating cyclin D1 expression. Eur Rev Med Pharmacol Sci. 24:9465–9472. 2020.PubMed/NCBI

Zeng Z, Zhao G, Zhu H, Nie L, He L, Liu J, Li R, Xiao S and Hua G: LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis. Cancer Cell Int. 20:3502020. View Article : Google Scholar : PubMed/NCBI

Yang D, Feng W, Zhuang Y, Liu J, Feng Z, Xu T, Wang W, Zhu Y and Wang Z: Long non-coding RNA linc00665 inhibits CDKN1C expression by binding to EZH2 and affects cisplatin sensitivity of NSCLC cells. Mol Ther Nucleic Acids. 23:1053–1065. 2021. View Article : Google Scholar : PubMed/NCBI

Yu Z, Wang G, Zhang C, Liu Y, Chen W, Wang H and Liu H: LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis. Cell Cycle. 19:300–316. 2020. View Article : Google Scholar : PubMed/NCBI

Boras B, Jones RM, Anson BJ, Arenson D, Aschenbrenner L, Bakowski MA, Beutler N, Binder J, Chen E, Eng H, et al: Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19. bioRxiv. 2021.

Gaston J, Cheradame L, Yvonnet V, Deas O, Poupon MF, Judde JG, Cairo S and Goffin V: Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents. Oncotarget. 7:77205–77224. 2016. View Article : Google Scholar : PubMed/NCBI

Duarte CW, Willey CD, Zhi D, Cui X, Harris JJ, Vaughan LK, Mehta T, McCubrey RO, Khodarev NN, Weichselbaum RR and Gillespie GY: Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner. PLoS One. 7:e296532012. View Article : Google Scholar : PubMed/NCBI

Wang J, Gao J, Chen Q, Zou W, Yang F, Wei C and Wang Z: LncRNA LINC01116 contributes to cisplatin resistance in lung adenocarcinoma. Onco Targets Ther. 13:9333–9348. 2020. View Article : Google Scholar : PubMed/NCBI

Geng W, Lv Z, Fan J, Xu J, Mao K, Yin Z, Qing W and Jin Y: Identification of the prognostic significance of somatic Mutation-Derived LncRNA signatures of genomic instability in lung adenocarcinoma. Front Cell Dev Biol. 9:6576672021. View Article : Google Scholar : PubMed/NCBI

Zeng L, Lyu X, Yuan J, Wang W, Zhao N, Liu B, Sun R, Meng X and Yang S: Long non-coding RNA LINC01116 is overexpressed in lung adenocarcinoma and promotes tumor proliferation and metastasis. Am J Transl Res. 12:4302–4313. 2020.PubMed/NCBI

Shang B, Li Z, Li M, Jiang S, Feng Z, Cao Z and Wang H: Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway. Thorac Cancer. 12:2093–2103. 2021. View Article : Google Scholar : PubMed/NCBI

Yao J, Chen X, Liu X, Li R, Zhou X and Qu Y: Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma. Cancer Cell Int. 21:3402021. View Article : Google Scholar : PubMed/NCBI

Faivre-Finn C, Vicente D, Kurata T, Planchard D, Paz-Ares L, Vansteenkiste JF, Spigel DR, Garassino MC, Reck M, Senan S, et al: Four-year survival with durvalumab after chemoradiotherapy in stage III NSCLC-an update from the PACIFIC trial. J Thorac Oncol. 16:860–867. 2021. View Article : Google Scholar : PubMed/NCBI

Chen Y, Gao M, Huang Z, Yu J and Meng X: SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: A focus on the mechanisms, advances, and future challenges. J Hematol Oncol. 13:1052020. View Article : Google Scholar : PubMed/NCBI

Nickoloff JA: Toward greater precision in cancer radiotherapy. Cancer Res. 81:3156–3157. 2021. View Article : Google Scholar : PubMed/NCBI

Tu X, Qin B, Zhang Y, Zhang C, Kahila M, Nowsheen S, Yin P, Yuan J, Pei H, Li H, et al: PD-L1 (B7-H1) Competes with the RNA exosome to regulate the DNA damage response and can be targeted to sensitize to radiation or chemotherapy. Mol Cell. 74:1215–1226.e4. 2019. View Article : Google Scholar : PubMed/NCBI

Tchelebi LT, Eng C, Messick CA, Hong TS, Ludmir EB, Kachnic LA and Zaorsky NG: Current treatment and future directions in the management of anal cancer. CA Cancer J Clin. 72:183–195. 2022. View Article : Google Scholar

Barcena-Varela M and Lujambio A: A novel long noncoding RNA finetunes the DNA damage response in hepatocellular carcinoma. Cancer Res. 81:4899–4900. 2021. View Article : Google Scholar : PubMed/NCBI

Liu JY, Chen YJ, Feng HH, Chen ZL, Wang YL, Yang JE and Zhuang SM: LncRNA SNHG17 interacts with LRPPRC to stabilize c-Myc protein and promote G1/S transition and cell proliferation. Cell Death Dis. 12:9702021. View Article : Google Scholar : PubMed/NCBI

Wang Y, Zhang L, Yang J and Sun R: LncRNA KCNQ1OT1 promotes cell proliferation, migration and invasion via regulating miR-129-5p/JAG1 axis in non-small cell lung cancer. Cancer Cell Int. 20:1442020. View Article : Google Scholar : PubMed/NCBI

Kang Y, Jia Y, Wang Q, Zhao Q, Song M, Ni R and Wang J: Long Noncoding RNA KCNQ1OT1 promotes the progression of non-small cell lung cancer via regulating miR-204-5p/ATG3 Axis. Onco Targets Ther. 12:10787–10797. 2019. View Article : Google Scholar : PubMed/NCBI

Dumanski JP, Halvardson J, Davies H, Rychlicka-Buniowska E, Mattisson J, Moghadam BT, Nagy N, Węglarczyk K, Bukowska-Strakova K, Danielsson M, et al: Immune cells lacking Y chromosome show dysregulation of autosomal gene expression. Cell Mol Life Sci. 78:4019–4033. 2021. View Article : Google Scholar : PubMed/NCBI

Lai IL, Chang YS, Chan WL, Lee YT, Yen JC, Yang CA, Hung SY and Chang JG: Male-specific long noncoding RNA TTTY15 inhibits non-small cell lung cancer proliferation and metastasis via TBX4. Int J Mol Sci. 20:34732019. View Article : Google Scholar : PubMed/NCBI

Yang CJ, Kumar A, Deng JZ, Raman V, Lui NS, D'Amico TA and Berry MF: A National analysis of short-term outcomes and long-term survival following thoracoscopic versus open lobectomy for clinical Stage II Non-Small-Cell lung cancer. Ann Surg. 273:595–605. 2021. View Article : Google Scholar

Zhang SB, Hong M, Sun XY, Huang D, He DH, Chen YF, Yuan Y and Liu YQ: Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2. Acta Materia Medica. 1:302–313. 2022. View Article : Google Scholar

Jiang N, Meng X, Mi H, Chi Y, Li S, Jin Z, Tian H, He J, Shen W, Tian H, et al: Circulating lncRNA XLOC_009167 serves as a diagnostic biomarker to predict lung cancer. Clin Chim Acta. 486:26–33. 2018. View Article : Google Scholar : PubMed/NCBI

Zhu Z, Wang H, Pang Y, Hu H, Zhang H and Wang W: Exosomal long non-coding RNA UCA1 functions as growth inhibitor in esophageal cancer. Aging (Albany NY). 12:20523–20539. 2020. View Article : Google Scholar : PubMed/NCBI

Yu AM and Tu MJ: Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination. Pharmacol Ther. 230:1079672022. View Article : Google Scholar :